Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum

Summary

the purpose of the study is to determine the safety and tolerability of VXA-A1.1, an adjuvanted adenoviral based influenza vaccine, when delivery is targeted to the ileum, using a radio controlled capsule. The secondary objective is to evaluate the immune response (cellular and humoral) of two doses of VXA-A1.1 oral vaccine.

Timeline

Start

2013-01

Primary completion

2014-10

Completion

2014-10

Drugs

Indications